Evidence map›Paper›PMID 38357149›Full record

ReviewAfrican health sciences2023

Covid-19 and non-communicable diseases (NCDs) in Africa: a narrative review.

Yusuff Azeez Olanrewaju, Amos Abimbola Oladunni, Kenneth Bitrus David, Yusuf Olalekan Babatunde, Ibrahim Abdulmumin Damilola, Oluwakorede Adedeji, Colette Chidozie Ahamefula

Open access · diamondAbstract readReview
In one paragraph

Review in African health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Yusuff Azeez OlanrewajuFaculty of Pharmacy, University of Ibadan, Oyo, Nigeria.
Amos Abimbola OladunniFaculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria, Nigeria.
Kenneth Bitrus DavidHull York Medical School, University of Hull, Hull, United Kingdom.
Yusuf Olalekan BabatundeFaculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, Nigeria.
Ibrahim Abdulmumin DamilolaFaculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, Nigeria.
Oluwakorede AdedejiFaculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, Nigeria.
Colette Chidozie AhamefulaFaculty of Pharmacy, Delta State University, Abraka.
University of Ilorin · NGAhmadu Bello University · NGUniversity of Hull · GBUniversity of Ibadan · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 popularly known as COVID-19 is the current pandemic ravaging the world. It has disrupted so many aspects of humans' life including the healthcare systems of all countries. While governments have instituted preventive measures such as social distancing, self-isolation and lockdown in a bid to control the spread of the virus, the absence of vaccine can lead to poor management of key risk factors (including unhealthy diets and physical inactivity) associated with NCDs and limited access to preventive health services can further contribute to development and progression of NCDs. This study provides a review of available evidences from PubMed, google scholar, online databases, and papers from other sources on the impact of COVID-19 pandemic on NCDs in Africa and emphasizes lessons from past pandemics that can be adopted to reduce the burden of the disease.

Indexed as

COVID-19Noncommunicable DiseasesCommunicable Disease ControlHumansPandemicsQuarantineSARS-CoV-2AfricaCOVID-19Non-Communicable DiseasesPandemics

Identifiers

PMID38357149
PMCPMC10862586
OpenAlexW4387570461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.